As the Academic Entrepreneur is hanging in Vancouver now networking around TED and chatting with folks such as Vinod Khosla and Ram Shiram, he thought it good timing to post this recent TED talk on financing drug discovery given by Roger Stein of MIT Sloan in November of 2013.
From Roger’s bio on the MIT Sloan website:
Roger Stein is a Senior Lecturer of Finance at the MIT Sloan School of Management.
He has been actively engaged in researching developing and implementing new approaches to applied risk modeling and financial prediction for almost 25 years. He and his teams have developed, implemented, and delivered products and services that have become industry benchmarks in banking and finance. He has written two full-length textbooks and has had his research published in a variety of academic, scientific, and professional journals. His current research interests are in the areas of systemic risk, model risk and validation, biomedical funding, and the interface between data mining and financial theory.
In addition to his academic work, Stein has also held a number of senior positions in industry. He is currently the chief analytics officer at State Street Global Exchange. Prior to this, he was managing director of Research and Academic Relations globally for Moody’s Corporation, president of Moody’s Research Labs (MRL), co-head of research at Moody’s KMV, and head of the managed funds group at MIS.
Stein serves on the editorial boards of several finance journals and also holds the position of Research Affiliate at the MIT Laboratory for Financial Engineering. He the founder and president of the Consortium for Systemic Risk Analytics; a member of the Advisory Council of the Museum of Mathematics; a member of the Business Practices Council of the Association to Advance Collegiate Schools of Business; and on the board of PlaNet Finance USA.
Stein holds a PhD and Master’s degree from the Stern School of Business, New York University.”
source: MIT Sloan http://mitsloan.mit.edu/about/detail.php?in_spseqno=53210